
Acclaro Medical
UltraClear is the world's first cold fiber fractionated laser solution.
Date | Investors | Amount | Round |
---|---|---|---|
* | $23.0m | Series B | |
Total Funding | 000k |
Related Content
UltraClear Laser, developed by Acclaro Medical, is a pioneering company in the aesthetic laser industry, offering the world's first cold fiber fractionated laser solution for skin rejuvenation. This innovative technology minimizes unwanted thermal damage while maximizing results for all skin types, significantly reducing pain and recovery time. The company serves a diverse clientele, including individuals seeking treatments for fine lines, deep wrinkles, sun spots, age spots, scars (including acne scars), and large pores. Operating in the global aesthetic and dermatological market, UltraClear Laser's business model revolves around selling advanced laser equipment to dermatologists, cosmetic surgeons, and medical spas. Revenue is generated through the sale of laser devices, maintenance services, and consumables. The company's technology stands out due to its superior efficacy, safety, and ability to deliver outstanding results with minimal discomfort and short downtime.
Keywords: cold fiber laser, skin rejuvenation, minimal pain, short downtime, aesthetic lasers, dermatology, anti-aging, collagen remodeling, hyperpigmentation, advanced technology.